Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
The Medical Clinics of North America|October 5, 2019
Pharmacogenomics: Prescribing PreciselyDyson T Wake, Nadim Ilbawi, Henry Mark Dunnenberger, et al.Pharmacogenomics|November 3, 2022
Pharmacogenomics of medications given via nonconventional administration routes: a scoping reviewSamantha Socco, Dyson T Wake, James C Lee, et al.Clinical Pharmacology and Therapeutics|August 8, 2021
Pharmacogenomic Clinical Decision Support: A Review, How-to Guide, and Future VisionDyson T Wake, D Max Smith, Sadaf Kazi, et al.Molecular and Cellular Biology|March 1, 1984
How damaged is the biologically active subpopulation of transfected DNA?C T Wake, T Gudewicz, T Porter, et al.Pharmacogenomics|January 19, 2021
Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparisonDyson T Wake, Gillian C Bell, David B Gregornik, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1982
Isolation of cDNA clones encoding HLA-DR alpha chainsC T Wake, E O Long, M Strubin, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 25, 2022
A clinician's guide for counseling patients on results of a multigene pharmacogenomic panelTeresa T Ho, Gillian Bell, Roseann S Gammal, et al.Human Immunology|September 1, 1983
Molecular analysis of the genes for human class II antigens of the major histocompatibility complexE O Long, J Gorski, P Rollini, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assayE O Long, C T Wake, M Strubin, et al.The EMBO Journal|January 1, 1982
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell lineE O Long, N Gross, C T Wake, et al.Pageof 4